Rajshree Polypack Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 9:49 pm

Competitors of Rajshree Polypack Ltd

All Competitor Stocks of Rajshree Polypack Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:45 am

Below is a detailed analysis of the quarterly data for Rajshree Polypack Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 82.52 Cr.. The value appears to be declining and may need further review. It has decreased from 90.05 Cr. (Mar 2025) to 82.52 Cr., marking a decrease of 7.53 Cr..
• For Expenses, as of Jun 2025, the value is 72.37 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 79.43 Cr. (Mar 2025) to 72.37 Cr., marking a decrease of 7.06 Cr..
• For Operating Profit, as of Jun 2025, the value is 10.15 Cr.. The value appears to be declining and may need further review. It has decreased from 10.62 Cr. (Mar 2025) to 10.15 Cr., marking a decrease of 0.47 Cr..
• For OPM %, as of Jun 2025, the value is 12.30%. The value appears strong and on an upward trend. It has increased from 11.79% (Mar 2025) to 12.30%, marking an increase of 0.51%.
• For Other Income, as of Jun 2025, the value is 1.93 Cr.. The value appears strong and on an upward trend. It has increased from 1.69 Cr. (Mar 2025) to 1.93 Cr., marking an increase of 0.24 Cr..
• For Interest, as of Jun 2025, the value is 2.85 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.48 Cr. (Mar 2025) to 2.85 Cr., marking an increase of 0.37 Cr..
• For Depreciation, as of Jun 2025, the value is 3.82 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.81 Cr. (Mar 2025) to 3.82 Cr., marking a decrease of 0.99 Cr..
• For Profit before tax, as of Jun 2025, the value is 5.41 Cr.. The value appears strong and on an upward trend. It has increased from 5.02 Cr. (Mar 2025) to 5.41 Cr., marking an increase of 0.39 Cr..
• For Tax %, as of Jun 2025, the value is 24.58%. The value appears to be improving (decreasing) as expected. It has decreased from 27.49% (Mar 2025) to 24.58%, marking a decrease of 2.91%.
• For Net Profit, as of Jun 2025, the value is 4.08 Cr.. The value appears strong and on an upward trend. It has increased from 3.65 Cr. (Mar 2025) to 4.08 Cr., marking an increase of 0.43 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.56. The value appears strong and on an upward trend. It has increased from 0.50 (Mar 2025) to 0.56, marking an increase of 0.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:35 am

Growth

Last Updated: September 5, 2025, 12:55 pm

Balance Sheet

Last Updated: September 10, 2025, 2:21 pm

Below is a detailed analysis of the balance sheet data for Rajshree Polypack Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 37.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 37.00 Cr..
• For Reserves, as of Mar 2025, the value is 132.00 Cr.. The value appears strong and on an upward trend. It has increased from 118.00 Cr. (Mar 2024) to 132.00 Cr., marking an increase of 14.00 Cr..
• For Borrowings, as of Mar 2025, the value is 116.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 87.00 Cr. (Mar 2024) to 116.00 Cr., marking an increase of 29.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 43.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 41.00 Cr. (Mar 2024) to 43.00 Cr., marking an increase of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 328.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 282.00 Cr. (Mar 2024) to 328.00 Cr., marking an increase of 46.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 128.00 Cr.. The value appears strong and on an upward trend. It has increased from 122.00 Cr. (Mar 2024) to 128.00 Cr., marking an increase of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 190.00 Cr.. The value appears strong and on an upward trend. It has increased from 152.00 Cr. (Mar 2024) to 190.00 Cr., marking an increase of 38.00 Cr..
• For Total Assets, as of Mar 2025, the value is 328.00 Cr.. The value appears strong and on an upward trend. It has increased from 282.00 Cr. (Mar 2024) to 328.00 Cr., marking an increase of 46.00 Cr..

Notably, the Reserves (132.00 Cr.) exceed the Borrowings (116.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Rajshree Polypack Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 5.00, marking a decrease of 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.09. This value is below the healthy minimum of 5. It has decreased from 2.39 (Mar 24) to 1.09, marking a decrease of 1.30.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 5. It has decreased from 2.39 (Mar 24) to 1.08, marking a decrease of 1.31.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.33. This value is within the healthy range. It has decreased from 6.66 (Mar 24) to 4.33, marking a decrease of 2.33.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.00. It has decreased from 41.83 (Mar 24) to 22.00, marking a decrease of 19.83.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.00. It has decreased from 41.83 (Mar 24) to 22.00, marking a decrease of 19.83.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 44.96. It has decreased from 74.86 (Mar 24) to 44.96, marking a decrease of 29.90.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.31. This value is within the healthy range. It has decreased from 9.84 (Mar 24) to 6.31, marking a decrease of 3.53.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.95. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 3.95, marking a decrease of 1.65.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.65. This value is within the healthy range. It has decreased from 3.31 (Mar 24) to 2.65, marking a decrease of 0.66.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.96. This value is below the healthy minimum of 2. It has decreased from 2.41 (Mar 24) to 1.96, marking a decrease of 0.45.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.09. This value is below the healthy minimum of 2. It has decreased from 2.36 (Mar 24) to 1.09, marking a decrease of 1.27.
• For PBDIT Margin (%), as of Mar 25, the value is 14.04. This value is within the healthy range. It has increased from 13.14 (Mar 24) to 14.04, marking an increase of 0.90.
• For PBIT Margin (%), as of Mar 25, the value is 8.78. This value is below the healthy minimum of 10. It has increased from 7.47 (Mar 24) to 8.78, marking an increase of 1.31.
• For PBT Margin (%), as of Mar 25, the value is 5.88. This value is below the healthy minimum of 10. It has increased from 4.42 (Mar 24) to 5.88, marking an increase of 1.46.
• For Net Profit Margin (%), as of Mar 25, the value is 4.36. This value is below the healthy minimum of 5. It has increased from 3.22 (Mar 24) to 4.36, marking an increase of 1.14.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.41. This value is below the healthy minimum of 8. It has decreased from 3.14 (Mar 24) to 2.41, marking a decrease of 0.73.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.93. This value is below the healthy minimum of 15. It has decreased from 5.63 (Mar 24) to 4.93, marking a decrease of 0.70.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.33. This value is within the healthy range. It has increased from 11.11 (Mar 24) to 14.33, marking an increase of 3.22.
• For Return On Assets (%), as of Mar 25, the value is 2.48. This value is below the healthy minimum of 5. It has decreased from 3.08 (Mar 24) to 2.48, marking a decrease of 0.60.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. It has increased from 0.09 (Mar 24) to 0.15, marking an increase of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.64. This value is within the healthy range. It has increased from 0.47 (Mar 24) to 0.64, marking an increase of 0.17.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.10. It has increased from 1.01 (Mar 24) to 1.10, marking an increase of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 1.25. This value is below the healthy minimum of 1.5. It has decreased from 1.29 (Mar 24) to 1.25, marking a decrease of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.67, marking an increase of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.73. This value is within the healthy range. It has increased from 3.98 (Mar 24) to 4.73, marking an increase of 0.75.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 6.62 (Mar 24) to 0.00, marking a decrease of 6.62.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.36 (Mar 24) to 0.00, marking a decrease of 2.36.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 93.38 (Mar 24) to 0.00, marking a decrease of 93.38.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.64 (Mar 24) to 0.00, marking a decrease of 97.64.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.85. This value is within the healthy range. It has increased from 4.30 (Mar 24) to 4.85, marking an increase of 0.55.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.51. This value is below the healthy minimum of 3. It has increased from 2.06 (Mar 24) to 2.51, marking an increase of 0.45.
• For Enterprise Value (Cr.), as of Mar 25, the value is 260.92. It has decreased from 368.92 (Mar 24) to 260.92, marking a decrease of 108.00.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 1.34 (Mar 24) to 0.79, marking a decrease of 0.55.
• For EV / EBITDA (X), as of Mar 25, the value is 5.64. This value is within the healthy range. It has decreased from 10.23 (Mar 24) to 5.64, marking a decrease of 4.59.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 24) to 0.50, marking a decrease of 0.59.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 93.37 (Mar 24) to 0.00, marking a decrease of 93.37.
• For Price / BV (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.03, marking a decrease of 0.92.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 24) to 0.50, marking a decrease of 0.59.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness